Stiles Financial Services’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,480
Closed -$260K 177
2023
Q3
$260K Sell
3,480
-707
-17% -$62.7K 0.14% 141
2023
Q2
$386K Sell
4,187
-324
-7% -$28.8K 0.19% 124
2023
Q1
$468K Sell
4,511
-501
-10% -$55.5K 0.25% 102
2022
Q4
$578K Sell
5,012
-40
-0.8% -$4.66K 0.33% 88
2022
Q3
$547K Buy
5,052
+492
+11% +$70.5K 0.33% 84
2022
Q2
$823K Buy
4,560
+23
+0.5% +$4.12K 0.49% 62
2022
Q1
$775K Buy
4,537
+20
+0.4% +$3.77K 0.39% 70
2021
Q4
$946K Buy
+4,517
New +$934K 0.46% 63

Other funds holding MED

Stiles Financial Services's MED Position: Q4 2023 in Review

Stiles Financial Services sold out of Medifast (MED) in Q4 2023, closing a stake of 3,480 shares — an estimated $260K sold.

Stiles Financial Services first reported a position in MED in Q4 2021 and held it in 8 quarters. The position peaked at $946K in Q4 2021. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Stiles Financial Services reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Stiles Financial Services sold 3,480 Medifast shares in Q4 2023, an estimated $260K.
  • Stiles Financial Services first reported a position in Medifast in Q4 2021 and held it in 8 quarters.
  • Stiles Financial Services's Medifast position peaked at $946K in Q4 2021.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Stiles Financial Services's 13F filing for Q4 2023, filed 26 Jan 2024.